Cigna Corporation


SKU: MCK-1-1 Category:


The Cigna Group exceeded analyst expectations in revenue and earnings, fueled by ongoing growth across its varied portfolio of companies. Cigna produced total revenues of $48.6 billion, adjusted earnings per share of $6.13, and cash flow from operations of $2.5 billion in the quarter. Their team is delighted with their overall performance during the quarter and in the year’s first half. They are strengthening their competitive position and growing their businesses by focusing on affordability and innovation. Another strong quarter was experienced by the company’s market-leading pharmacy, care, and benefits portfolio at Evernorth Health Services. Cigna’s pharmaceutical benefits division, Express Scripts, uses its considerable clinical knowledge and close relationships to bring new ideas and solutions to the people it serves. Besides, they launched independent Rx, a ground-breaking initiative to empower rural pharmacists crucial in enhancing access for millions of Americans. Cigna Healthcare also experienced organic client growth, demonstrating how effectively their consultative approach and skills are still in demand. During the quarter, Cigna Healthcare’s International Health business introduced a customized health benefits plan specifically designed to cater to the well-being and overall vitality of those aged 60 and over who are part of the globally mobile population. We give the company a ‘Hold’ rating with a revised target price.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!